Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Warrick Pharmaceuticals Launches Generic Ribavirin Product

By Pharmaceutical Processing | April 13, 2004

KENILWORTH, NJ (April 12, 2004) – Warrick Pharmaceuticals, a wholly owned subsidiary of Schering-Plough Corp., has launched a generic ribavirin product in the United States.

Schering-Plough had previously entered into a licensing agreement with Three Rivers Pharmaceuticals, LLC regarding U.S. ribavirin patents. Under terms of the agreement and as a result of launching Warrick ribavirin, Schering-Plough will not receive a royalty from Three Rivers on sales of Three Rivers’ generic ribavirin product, the company said. Financial terms of the licensing agreement have not been disclosed.Schering-Plough noted that the market for generic pharmaceutical products is volatile, particularly at launch, and it will price its generic ribavirin product according to market conditions and applicable regulations.

Schering-Plough markets ribavirin USP capsules under the brand name Rebetol. The company said it expected generic competition for Rebetol in the U.S. market in 2004.

Schering-Plough is a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE